The global antipyretic drug market is anticipated to grow at a CAGR of 2.2% during the forecast period. the growth of the global antipyretic drug market is driven by growing number of bacterial and viral infections globally and also medical treatment costs has seen dramatic growth globally. In january 2023, hyloris announces commercial partnership for maxigesic iv in 9 european...